Development of a toxicogenomics in vitro assay for the efficient characterization of compounds

Author： Yang Yi Abel Stephen J Ciurlionis Rita Waring Jeffrey F

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.2, 2006-03, pp. : 177-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Toxicogenomics

Current Drug Metabolism, Vol. 9, Iss. 3, 2008-03 ,pp. : 250-254

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicogenomics: an opportunity to optimise drug development and safety evaluation

By Kolaja Kyle L Kramer Jeffrey A

Expert Opinion on Drug Safety, Vol. 1, Iss. 3, 2002-09 ,pp. : 275-286

Informa Healthcare

Access to resources Recommend Favorite

Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds

By Fernandes C.M. Teresa Vieira M. B. Veiga F.J.

European Journal of Pharmaceutical Sciences, Vol. 15, Iss. 1, 2002-02 ,pp. : 79-88

Elsevier

Access to resources Recommend Favorite

A Novel Plated Hepatocyte Relay Assay (PHRA) for In Vitro Evaluation of Hepatic Metabolic Clearance of Slowly Metabolized Compounds

Drug Metabolism Letters, Vol. 10, Iss. 1, 2016-03 ,pp. : 3-15

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Toxicogenomics in the Development of Safe, Efficacious and Novel Anti-microbial Therapies.

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 13, Iss. 3, 2013-06 ,pp. : 206-214

Bentham Science Publishers

Access to resources Recommend Favorite